Biocon Chairperson Kiran Mazumdar Shaw on Sunday hit out at the government capping COVID-19 vaccine price at Rs 250 at private hospitals, saying vaccine companies "feel betrayed" as it is too low to sustain.
Reacting to a report that the health ministry has fixed Rs 250 per shot at private hospitals and health centres, she tweeted, "We r (sic) crushing instead of incentivising vaccine industry."
She further said, "Covid Vaccine Jab Capped At Rs 250 At Private Hospitals: Government - understand vaccine cos (sic) feel betrayed as price is too low to sustain."
Mazumdar-Shaw asked, "If WHO has agreed to USD 3 per dose, why beat them down to USD 2?"
The government's capping of the vaccine price at private hospitals comes at a time when India is preparing to vaccinate people aged above 60 years and those over 45 with co-morbidities from March 1.
The COVID-19 vaccine will be given free of cost at government hospitals, while people will need to pay for it at private facilities.
It is understood that the Rs 250 ceiling per dose includes Rs 150 per dose of vaccine plus Rs 100 service charge.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)